Gynecomastia Differential Diagnosis
The differential diagnosis for gynecomastia includes breast cancer, pseudogynecomastia (fatty tissue deposition), and benign subcutaneous masses (lipomas, epidermal cysts, oil cysts), with breast cancer being the most critical diagnosis to exclude despite gynecomastia being the most common cause of male breast enlargement. 1
Primary Differential Considerations
1. Male Breast Cancer
- Accounts for <1% of all breast cancers but is the most important diagnosis to rule out 1
- Typically occurs in older men (median age 63 years) 1
- Key distinguishing features:
- Usually presents with hard, fixed mass (not soft/rubbery like gynecomastia)
- Associated symptoms: skin or nipple retraction, nipple discharge
- Often eccentric location (not directly subareolar)
- Typically unilateral and painless
- Presents at advanced stage with larger tumor size and higher probability of nodal metastases 1
- Critical caveat: Approximately 50% of men with breast cancer have coexisting gynecomastia, but gynecomastia itself is NOT a risk factor for breast cancer 1
2. True Gynecomastia
- Most common cause of male breast symptoms 1
- Characteristic presentation:
- Underlying etiologies to investigate: 2, 3, 4
- Physiologic: Neonates, puberty, men >65 years
- Medications/drugs: Spironolactone, cardiac medications, antihypertensives, recreational drugs
- Endocrine disorders: Hypogonadism, hyperthyroidism, testicular tumors (hCG-secreting)
- Systemic disease: Chronic liver disease, chronic kidney disease
- Hormonal imbalance: Increased estrogen or decreased androgen action
3. Pseudogynecomastia
- Excess fatty tissue deposition without true glandular proliferation 1
- Common in patients with elevated body mass index 1
- Distinguishing feature: No palpable firm subareolar tissue on examination
- Mammography can definitively differentiate this from true gynecomastia 1
4. Benign Subcutaneous Masses
- Lipomas: Soft, mobile, fatty masses 1
- Epidermal inclusion cysts: Firm, mobile, often with visible punctum
- Oil cysts: Post-traumatic fat necrosis 1
- These are commonly encountered and typically distinguishable by location (not subareolar) and characteristics
Diagnostic Algorithm Based on Clinical Presentation
When Clinical Examination is Consistent with Gynecomastia/Pseudogynecomastia:
- No imaging routinely indicated 1
- Most cases diagnosed clinically without imaging
- Proceed with laboratory evaluation for underlying causes 2:
- Total testosterone, estradiol, LH, hCG, prolactin
- Additional tests as indicated: FSH, TSH, fT4, AFP, DHEA, liver/kidney function
When Clinical Examination is Indeterminate or Suspicious:
- Imaging IS indicated to differentiate benign from malignant disease 1
- Age-based approach:
Critical Clinical Pitfalls to Avoid
Do not assume bilateral presentation excludes cancer - 50% of men with breast cancer have coexisting gynecomastia 1
Do not order routine imaging for clinically obvious gynecomastia - This leads to unnecessary biopsies without improving cancer detection 1
Always obtain medication history - Many cardiac and antihypertensive medications cause gynecomastia 3, 4
Perform testicular examination - Testicular tumors (especially Leydig cell tumors) can present with gynecomastia due to hCG or estrogen production 2, 4
Consider systemic disease - Chronic liver disease and hyperthyroidism are important reversible causes 2, 3, 4
When to Suspect Malignancy Over Benign Gynecomastia
Immediate red flags requiring imaging:
- Hard, fixed, or eccentric mass
- Skin changes or nipple retraction
- Bloody nipple discharge
- Unilateral presentation in older men (>60 years)
- Rapid growth
- Axillary lymphadenopathy